Reply by Authors
Urol Pract
.
2022 May;9(3):245.
doi: 10.1097/UPJ.0000000000000294.02.
Epub 2022 Feb 2.
Authors
Diego Aguilar Palacios
1
,
Brigid Wilson
2
,
Patrick Michael
1
,
Olli Saarela
3
,
Mustafa Ascha
4
,
Sunah Song
4
,
Molly E DeWitt-Foy
1
,
Keith Lawson
5
,
Jill Barnholtz-Sloan
4
,
Antonio Finelli
5
,
Steven C Campbell
1
,
Robert Abouassaly
1
2
Affiliations
1
Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
2
Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio.
3
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
4
Cleveland Institute of Computational Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
5
Division of Urology, Department of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
PMID:
37145553
DOI:
10.1097/UPJ.0000000000000294.02
No abstract available